Skin rejuvenation: use of Platelet Rich Plasma (PRP) and its association with Ozone Therapy

niversidade Brasil0 个研究点开始时间: 2023年7月11日最近更新: 2023年7月26日

适应症

试验速览

暂无简介。

•women; age range of 40 and 60 years; phototype II to IV according to the Fitzpatrick scale; presence of signs of facial photoaging grade II to IV according to the Glogau scale; blood count with normal platelet count (150,000 to 350,000 uL); consent to participate in the study to sign the informed consent;

•smokers; pregnant or breastfeeding women; history of neoplasia; ablative chemical or physical peeling in the last 6 months; use of botulinum toxin or fillers with facial implants with absorbable material in the last six months; performance of surgical procedures (rhytidoplasty and/or blepharoplasty); patient unable to use photoprotection throughout the treatment period; patients with a history of keloids or hypertrophic scarring; patients with infected or inflamed skin lesion on the face in the last 12 months; underlying diseases such as uncontrolled systemic arterial hypertension; renal liver disease; hematological (coagulopathies and/or purpura, glucose 6-phosphate deficiency); inflammatory; rheumatological; with diabetes; platelet count below 150,000/uL; of hypersensitivity to ozone therapy treatment; refusal to sign the informed consent form; still, the discontinuity criteria were established: withdrawal of the participants; two consecutive absences; present any disorder/infection that implies the use of antibiotics throughout the study;

发起方

niversidade Brasil